SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Xiao-Min Wang, Brian Walitt, Leorey Saligan, Agnes FY Tiwari, Chi Wai Cheung, Zhang-Jin Zhang, Chemobrain: A critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy, Cytokine, 2015,

    CrossRef

  2. You have free access to this content2
    Jeffrey S. Wefel, Shelli R. Kesler, Kyle R. Noll, Sanne B. Schagen, Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults, CA: A Cancer Journal for Clinicians, 2015, 65, 1
  3. 3
    Marta Simó, James C. Root, Lucía Vaquero, Pablo Ripollés, Josep Jové, Tim Ahles, Arturo Navarro, Felipe Cardenal, Jordi Bruna, Antoni Rodríguez-Fornells, Cognitive and Brain Structural Changes in a Lung Cancer Population, Journal of Thoracic Oncology, 2015, 10, 1, 38

    CrossRef

  4. 4
    Nathan W. Churchill, Bernadine Cimprich, Mary K. Askren, Patricia A. Reuter-Lorenz, Mi Sook Jung, Scott Peltier, Marc G. Berman, Scale-free brain dynamics under physical and psychological distress: Pre-treatment effects in women diagnosed with breast cancer, Human Brain Mapping, 2015, 36, 2
  5. 5
    Jordan Sorokin, Babak Saboury, JinHyung Albert Ahn, Mateen Moghbel, Sandip Basu, Abass Alavi, Adverse Functional Effects of Chemotherapy on Whole-Brain Metabolism, Clinical Nuclear Medicine, 2014, 39, 1, e35

    CrossRef

  6. 6
    Osamu Shibayama, Kazuhiro Yoshiuchi, Masatoshi Inagaki, Yutaka Matsuoka, Eisho Yoshikawa, Yuriko Sugawara, Tatsuo Akechi, Noriaki Wada, Shigeru Imoto, Koji Murakami, Asao Ogawa, Akira Akabayashi, Yosuke Uchitomi, Association between adjuvant regional radiotherapy and cognitive function in breast cancer patients treated with conservation therapy, Cancer Medicine, 2014, 3, 3
  7. 7
    M. Dubois, N. Lapinte, V. Villier, C. Lecointre, V. Roy, M.-C. Tonon, P. Gandolfo, F. Joly, P. Hilber, H. Castel, Chemotherapy-induced long-term alteration of executive functions and hippocampal cell proliferation: Role of glucose as adjuvant, Neuropharmacology, 2014, 79, 234

    CrossRef

  8. 8
    Kim Edelstein, Lori J. Bernstein, Cognitive Dysfunction after Chemotherapy For Breast Cancer, Journal of the International Neuropsychological Society, 2014, 20, 04, 351

    CrossRef

  9. 9
    Teresita L. Briones, Julie Woods, Dysregulation in myelination mediated by persistent neuroinflammation: Possible mechanisms in chemotherapy-related cognitive impairment, Brain, Behavior, and Immunity, 2014, 35, 23

    CrossRef

  10. 10
    Vincent Koppelmans, Marius de Groot, Michiel B. de Ruiter, Willem Boogerd, Caroline Seynaeve, Meike W. Vernooij, Wiro J. Niessen, Sanne B. Schagen, Monique M.B. Breteler, Global and focal white matter integrity in breast cancer survivors 20 years after adjuvant chemotherapy, Human Brain Mapping, 2014, 35, 3
  11. 11
    Jörg Dietrich, Joshua P. Klein, Imaging of Cancer Therapy–Induced Central Nervous System Toxicity, Neurologic Clinics, 2014, 32, 1, 147

    CrossRef

  12. 12
    Jochen Kaiser, Christoph Bledowski, Jörg Dietrich, Neural correlates of chemotherapy-related cognitive impairment, Cortex, 2014, 54, 33

    CrossRef

  13. 13
    Katharina Bösche, Karin Weissenborn, Uwe Christians, Oliver Witzke, Harald Engler, Manfred Schedlowski, Martin Hadamitzky, Neurobehavioral consequences of small molecule-drug immunosuppression, Neuropharmacology, 2014,

    CrossRef

  14. 14
    Michelle C. Janelsins, Shelli R. Kesler, Tim A. Ahles, Gary R. Morrow, Prevalence, mechanisms, and management of cancer-related cognitive impairment, International Review of Psychiatry, 2014, 26, 1, 102

    CrossRef

  15. 15
    Laura L. Horky, Victor H. Gerbaudo, Alexander Zaitsev, Wen Plesniak, Jon Hainer, Usha Govindarajulu, Ron Kikinis, Jörg Dietrich, Systemic chemotherapy decreases brain glucose metabolism, Annals of Clinical and Translational Neurology, 2014, 1, 10
  16. 16
    Carolina de Medeiros Rimkus, Celi Santos Andrade, Claudia da Costa Leite, Alexander M. McKinney, Leandro Tavares Lucato, Toxic Leukoencephalopathies, Including Drug, Medication, Environmental, and Radiation-Induced Encephalopathic Syndromes, Seminars in Ultrasound, CT and MRI, 2014, 35, 2, 97

    CrossRef

  17. 17
    D. D. Correa, J. C. Root, R. Baser, D. Moore, K. K. Peck, E. Lis, T. B. Shore, H. T. Thaler, A. Jakubowski, N. Relkin, A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients, Brain Imaging and Behavior, 2013, 7, 4, 478

    CrossRef

  18. 18
    Susan K. Conroy, Brenna C. McDonald, Dori J. Smith, Lyndsi R. Moser, John D. West, Lisa M. Kamendulis, James E. Klaunig, Victoria L. Champion, Frederick W. Unverzagt, Andrew J. Saykin, Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage, Breast Cancer Research and Treatment, 2013, 137, 2, 493

    CrossRef

  19. 19
    Brenna C. McDonald, Andrew J. Saykin, Alterations in brain structure related to breast cancer and its treatment: chemotherapy and other considerations, Brain Imaging and Behavior, 2013, 7, 4, 374

    CrossRef

  20. 20
    Bénédicte Giffard, Armelle Viard, Jacques Dayan, Nastassja Morel, Florence Joly, Francis Eustache, Autobiographical Memory, Self, and Stress-Related Psychiatric Disorders: Which Implications in Cancer Patients?, Neuropsychology Review, 2013, 23, 2, 157

    CrossRef

  21. 21
    Marta Simó, Xavier Rifà-Ros, Antoni Rodriguez-Fornells, Jordi Bruna, Chemobrain: A systematic review of structural and functional neuroimaging studies, Neuroscience & Biobehavioral Reviews, 2013, 37, 8, 1311

    CrossRef

  22. 22
    Julie A. Dumas, Jenna Makarewicz, Geoffrey J. Schaubhut, Robert Devins, Kimberly Albert, Kim Dittus, Paul A. Newhouse, Chemotherapy altered brain functional connectivity in women with breast cancer: a pilot study, Brain Imaging and Behavior, 2013, 7, 4, 524

    CrossRef

  23. 23
    Erin O’Farrell, Joyce MacKenzie, Barbara Collins, Clearing the Air: A Review of Our Current Understanding of “Chemo Fog”, Current Oncology Reports, 2013, 15, 3, 260

    CrossRef

  24. 24
    Emi Miki, Tsuyoshi Kataoka, Hitoshi Okamura, Clinical usefulness of the Frontal Assessment Battery at bedside (FAB) for elderly cancer patients, Supportive Care in Cancer, 2013, 21, 3, 857

    CrossRef

  25. 25
    Jeanne S. Mandelblatt, Arti Hurria, Brenna C. McDonald, Andrew J. Saykin, Robert A. Stern, John W. VanMeter, Meghan McGuckin, Tiffani Traina, Neelima Denduluri, Scott Turner, Darlene Howard, Paul B. Jacobsen, Tim Ahles, Cognitive Effects of Cancer and Its Treatments at the Intersection of Aging: What Do We Know; What Do We Need to Know?, Seminars in Oncology, 2013, 40, 6, 709

    CrossRef

  26. 26
    Shelli Kesler, S.M. Hadi Hosseini, Charles Heckler, Michelle Janelsins, Oxana Palesh, Karen Mustian, Gary Morrow, Cognitive Training for Improving Executive Function in Chemotherapy-Treated Breast Cancer Survivors, Clinical Breast Cancer, 2013, 13, 4, 299

    CrossRef

  27. 27
    Aaron K. Holley, Sanjit Kumar Dhar, Daret K. St. Clair, Curbing cancer's sweet tooth: Is there a role for MnSOD in regulation of the Warburg effect?, Mitochondrion, 2013, 13, 3, 170

    CrossRef

  28. 28
    S. R. Kesler, J. S. Wefel, S. M. H. Hosseini, M. Cheung, C. L. Watson, F. Hoeft, Default mode network connectivity distinguishes chemotherapy-treated breast cancer survivors from controls, Proceedings of the National Academy of Sciences, 2013, 110, 28, 11600

    CrossRef

  29. 29
    Rocío A. López Zunini, Carole Scherling, Nancy Wallis, Barbara Collins, Joyce MacKenzie, Catherine Bielajew, Andra M. Smith, Differences in verbal memory retrieval in breast cancer chemotherapy patients compared to healthy controls: a prospective fMRI study, Brain Imaging and Behavior, 2013, 7, 4, 460

    CrossRef

  30. 30
    Xingui Chen, Chunyan Zhu, Jingjing Li, Linlin Qiu, Long Zhang, Fengqiong Yu, Rong Ye, Jingjie Zhang, Kai Wang, Dissociation of decision making under ambiguity and decision making under risk in breast cancer patients receiving adjuvant chemotherapy: A neuropsychological study, Brain Research, 2013, 1533, 63

    CrossRef

  31. 31
    Brenna C. McDonald, Susan K. Conroy, Dori J. Smith, John D. West, Andrew J. Saykin, Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: A replication and extension study, Brain, Behavior, and Immunity, 2013, 30, S117

    CrossRef

  32. 32
    K. L. Pomykala, M. B. de Ruiter, S. Deprez, B. C. McDonald, D. H. S. Silverman, Integrating imaging findings in evaluating the post-chemotherapy brain, Brain Imaging and Behavior, 2013, 7, 4, 436

    CrossRef

  33. 33
    Vincent Koppelmans, Monique M.B. Breteler, Willem Boogerd, Caroline Seynaeve, Sanne B. Schagen, Late effects of adjuvant chemotherapy for adult onset non-CNS cancer; cognitive impairment, brain structure and risk of dementia, Critical Reviews in Oncology/Hematology, 2013, 88, 1, 87

    CrossRef

  34. 34
    Adeline Rollin-Sillaire, Xavier Delbeuck, Marianne Pollet, Marie-Anne Mackowiak, Pierre Lenfant, Marie-Pierre Noel, Thierry Facon, Xavier Leleu, Florence Pasquier, Emilie Le Rhun, Memory loss during lenalidomide treatment: a report on two cases, BMC Pharmacology and Toxicology, 2013, 14, 1, 41

    CrossRef

  35. 35
    Andrew J. Saykin, Michiel B. de Ruiter, Brenna C. McDonald, Sabine Deprez, Daniel H. S. Silverman, Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: Current status and recommendations for future research, Brain Imaging and Behavior, 2013, 7, 4, 363

    CrossRef

  36. 36
    Kelly N. Holohan, Diane Von Ah, Brenna C. McDonald, Andrew J. Saykin, Neuroimaging, Cancer, and Cognition: State of the Knowledge, Seminars in Oncology Nursing, 2013, 29, 4, 280

    CrossRef

  37. 37
    Wendy L. Nelson, Jerry Suls, New Approaches to Understand Cognitive Changes Associated With Chemotherapy for Non-Central Nervous System Tumors, Journal of Pain and Symptom Management, 2013, 46, 5, 707

    CrossRef

  38. 38
    Carole Scherling, Andra Smith, Opening up the Window into “Chemobrain”: A Neuroimaging Review, Sensors, 2013, 13, 3, 3169

    CrossRef

  39. 39
    Hitoshi Tanimukai, Daisuke Kanayama, Tsubasa Omi, Masatoshi Takeda, Takashi Kudo, Paclitaxel induces neurotoxicity through endoplasmic reticulum stress, Biochemical and Biophysical Research Communications, 2013, 437, 1, 151

    CrossRef

  40. 40
    Joanna E. Fardell, Janette Vardy, Ian N. Johnston, The short and long term effects of docetaxel chemotherapy on rodent object recognition and spatial reference memory, Life Sciences, 2013, 93, 17, 596

    CrossRef

  41. 41
    Jennifer Bruno, S.M. Hadi Hosseini, Shelli Kesler, Altered resting state functional brain network topology in chemotherapy-treated breast cancer survivors, Neurobiology of Disease, 2012, 48, 3, 329

    CrossRef

  42. 42
    S M Hosseini, Della Koovakkattu, Shelli R Kesler, Altered small-world properties of gray matter networks in breast cancer, BMC Neurology, 2012, 12, 1, 28

    CrossRef

  43. You have free access to this content43
    Tim A. Ahles, Brain vulnerability to chemotherapy toxicities, Psycho-Oncology, 2012, 21, 11
  44. 44
    Jeffrey S. Wefel, Sanne B. Schagen, Chemotherapy-Related Cognitive Dysfunction, Current Neurology and Neuroscience Reports, 2012, 12, 3, 267

    CrossRef

  45. 45
    Heather S. L. Jim, Brent Small, Sheri Hartman, Jamie Franzen, Shannon Millay, Kristin Phillips, Paul B. Jacobsen, Margaret Booth-Jones, Joseph Pidala, Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation, Cancer, 2012, 118, 13
  46. 46
    Denise D. Correa, Lisa M. Hess, Cognitive function and quality of life in ovarian cancer, Gynecologic Oncology, 2012, 124, 3, 404

    CrossRef

  47. 47
    Vincent Koppelmans, Michiel B. de Ruiter, Fedde van der Lijn, Willem Boogerd, Caroline Seynaeve, Aad van der Lugt, Henri Vrooman, Wiro J. Niessen, Monique M. B. Breteler, Sanne B. Schagen, Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy, Breast Cancer Research and Treatment, 2012, 132, 3, 1099

    CrossRef

  48. 48
    Michiel B. de Ruiter, Liesbeth Reneman, Willem Boogerd, Dick J. Veltman, Matthan Caan, Gwenaëlle Douaud, Cristina Lavini, Sabine C. Linn, Epie Boven, Frits S.A.M. van Dam, Sanne B. Schagen, Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging, Human Brain Mapping, 2012, 33, 12
  49. 49
    Aaron K. Holley, Sanjit Kumar Dhar, Yong Xu, Daret K. St. Clair, Manganese superoxide dismutase: beyond life and death, Amino Acids, 2012, 42, 1, 139

    CrossRef

  50. 50
    Caroline H. Walker, Barbara A. Drew, James W. Antoon, Alan V. Kalueff, Barbara S. Beckman, Neurocognitive Effects of Chemotherapy and Endocrine Therapies in the Treatment of Breast Cancer: Recent Perspectives, Cancer Investigation, 2012, 30, 2, 135

    CrossRef

  51. 51
    Carole Scherling, Barbara Collins, Joyce MacKenzie, Catherine Bielajew, Andra Smith, Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: A functional magnetic resonance imaging study, Journal of Clinical and Experimental Neuropsychology, 2012, 34, 5, 543

    CrossRef

  52. 52
    Karin Gehring, Jan Anne Roukema, Margriet M Sitskoorn, Review of recent studies on interventions for cognitive deficits in patients with cancer, Expert Review of Anticancer Therapy, 2012, 12, 2, 255

    CrossRef

  53. 53
    Melissa J. Sharpe, Joanna E. Fardell, Janette Vardy, Ian N. Johnston, The chemotherapy agent oxaliplatin impairs the renewal of fear to an extinguished conditioned stimulus in rats, Behavioural Brain Research, 2012, 227, 1, 295

    CrossRef

  54. 54
    Svetlana Prokasheva, Yifat Faran, Julie Cwikel, David B. Geffen, Analysis of Memory Deficits Following Chemotherapy in Breast Cancer Survivors: Evidence from the Doors and People Test, Journal of Psychosocial Oncology, 2011, 29, 5, 499

    CrossRef

  55. 55
    J E Fardell, J Vardy, I N Johnston, G Winocur, Chemotherapy and Cognitive Impairment: Treatment Options, Clinical Pharmacology & Therapeutics, 2011, 90, 3
  56. 56
    Sabine Deprez, Frederic Amant, Refika Yigit, Kathleen Porke, Judith Verhoeven, Jan Van den Stock, Ann Smeets, Marie-Rose Christiaens, Alexander Leemans, Wim Van Hecke, Joris Vandenberghe, Mathieu Vandenbulcke, Stefan Sunaert, Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients, Human Brain Mapping, 2011, 32, 3
  57. 57
    Gordon Winocur, Malcolm A. Binns, Ian Tannock, Donepezil reduces cognitive impairment associated with anti-cancer drugs in a mouse model, Neuropharmacology, 2011, 61, 8, 1222

    CrossRef

  58. 58
    Andreas A. Argyriou, Konstantinos Assimakopoulos, Gregoris Iconomou, Fotini Giannakopoulou, Haralabos P. Kalofonos, Either Called “Chemobrain” or “Chemofog,” the Long-Term Chemotherapy-Induced Cognitive Decline in Cancer Survivors Is Real, Journal of Pain and Symptom Management, 2011, 41, 1, 126

    CrossRef

  59. 59
    Laura Lyons, Maha ElBeltagy, Jariya Umka, Rachel Markwick, Carla Startin, Geoffrey Bennett, Peter Wigmore, Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy, Psychopharmacology, 2011, 215, 1, 105

    CrossRef

  60. 60
    M. Lange, B. Giffard, F. Eustache, N. Morel, S. Noal, F. Joly, Impact de la chimiothérapie adjuvante sur les fonctions cognitives dans le cancer du sein: revue de la littérature, Psycho-Oncologie, 2011, 5, 1, 3

    CrossRef

  61. 61
    Vincent Koppelmans, Sanne B. Schagen, Mariëlle M.F. Poels, Willem Boogerd, Caroline Seynaeve, Aad van der Lugt, Monique M.B. Breteler, Incidental findings on brain Magnetic Resonance Imaging in long-term survivors of breast cancer treated with adjuvant chemotherapy, European Journal of Cancer, 2011, 47, 17, 2531

    CrossRef

  62. 62
    Jeffrey S Wefel, Janette Vardy, Tim Ahles, Sanne B Schagen, International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer, The Lancet Oncology, 2011, 12, 7, 703

    CrossRef

  63. 63
    Aaron K. Holley, Vasudevan Bakthavatchalu, Joyce M. Velez-Roman, Daret K. St. Clair, Manganese Superoxide Dismutase: Guardian of the Powerhouse, International Journal of Molecular Sciences, 2011, 12, 12, 7114

    CrossRef

  64. 64
    Denise D. Correa, Qin Zhou, Howard T. Thaler, Michelle Maziarz, Karen Hurley, Martee L. Hensley, Cognitive functions in long-term survivors of ovarian cancer, Gynecologic Oncology, 2010, 119, 2, 366

    CrossRef

  65. 65
    Brenna C. McDonald, Susan K. Conroy, Tim A. Ahles, John D. West, Andrew J. Saykin, Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study, Breast Cancer Research and Treatment, 2010, 123, 3, 819

    CrossRef

  66. 66
    Michelle C. Janelsins, Joseph A. Roscoe, Michel J. Berg, Bryan D. Thompson, Mark J. Gallagher, Gary R. Morrow, Charles E. Heckler, Pascal Jean-Pierre, Lisa A. Opanashuk, Robert A. Gross, IGF-1 Partially Restores Chemotherapy-Induced Reductions in Neural Cell Proliferation in Adult C57BL/6 Mice, Cancer Investigation, 2010, 28, 5, 544

    CrossRef

  67. 67
    R. B. Raffa, Is a picture worth a thousand (forgotten) words?: neuroimaging evidence for the cognitive deficits in ‘chemo-fog’/’chemo-brain’, Journal of Clinical Pharmacy and Therapeutics, 2010, 35, 1
  68. 68
    Stephanie A. Reid-Arndt, Catherine Hsieh, Michael C. Perry, Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer, Psycho-Oncology, 2010, 19, 5
  69. 69
    Janette Vardy, Haryana Dhillon, The fog hasn’t lifted on “chemobrain” yet: ongoing uncertainty regarding the effects of chemotherapy and breast cancer on cognition, Breast Cancer Research and Treatment, 2010, 123, 1, 35

    CrossRef

  70. 70
    Álvaro Pinto Marín, Andrés Redondo Sánchez, Enrique Espinosa Arranz, Pilar Zamora Auñón, Manuel González Barón, Adjuvant Chemotherapy for Breast Cancer and Cognitive Impairment, Southern Medical Journal, 2009, 102, 9, 929

    CrossRef

  71. 71
    Jamie S. Myers, Chemotherapy-Related Cognitive Impairment, Clinical Journal of Oncology Nursing, 2009, 13, 4, 413

    CrossRef

  72. 72
    Carole Soussain, Damien Ricard, John R Fike, Jean-Jacques Mazeron, Dimitri Psimaras, Jean-Yves Delattre, CNS complications of radiotherapy and chemotherapy, The Lancet, 2009, 374, 9701, 1639

    CrossRef

  73. 73
    KATHARINE JEAN VEARNCOMBE, NANCY A. PACHANA, Impact of health, treatment and psychological factors on cognitive functioning after chemotherapy for early breast cancer, Australian Psychologist, 2009, 44, 4
  74. 74
    Fleur Huang, Munir Alrefae, Adrian Langleben, David Roberge, Prophylactic Cranial Irradiation in Advanced Breast Cancer: A Case for Caution, International Journal of Radiation Oncology*Biology*Physics, 2009, 73, 3, 752

    CrossRef

  75. 75
    Jame Abraham, Marc W. Haut, Maria T. Moran, Shannon Filburn, Susan Lemiuex, Hiroto Kuwabara, Adjuvant Chemotherapy for Breast Cancer: Effects on Cerebral White Matter Seen in Diffusion Tensor Imaging, Clinical Breast Cancer, 2008, 8, 1, 88

    CrossRef

  76. 76
    John J. Foley, Robert B. Raffa, Ellen A. Walker, Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory, Psychopharmacology, 2008, 199, 4, 527

    CrossRef

  77. 77
    Baudewijntje P.C. Kreukels, Hans L. Hamburger, Michiel B. de Ruiter, Frits S.A.M. van Dam, K. Richard Ridderinkhof, Willem Boogerd, Sanne B. Schagen, ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy, Clinical Neurophysiology, 2008, 119, 3, 533

    CrossRef

  78. 78
    Denise D. Correa, Tim A. Ahles, Neurocognitive Changes in Cancer Survivors, The Cancer Journal, 2008, 14, 6, 396

    CrossRef

  79. 79
    Jeffrey S. Wefel, Mariana E. Witgert, Christina A. Meyers, Neuropsychological Sequelae of Non-Central Nervous System Cancer and Cancer Therapy, Neuropsychology Review, 2008, 18, 2, 121

    CrossRef

  80. 80
    Baudewijntje P.C. Kreukels, Frits S.A.M. van Dam, K. Richard Ridderinkhof, Willem Boogerd, Sanne B. Schagen, Persistent Neurocognitive Problems After Adjuvant Chemotherapy for Breast Cancer, Clinical Breast Cancer, 2008, 8, 1, 80

    CrossRef

  81. 81
    Benjamin W. Corn, Jennifer Moughan, Jonathan P.S. Knisely, Sherry W. Fox, Arnab Chakravarti, W.K. Alfred Yung, Walter J. Curran, H. Ian Robins, David G. Brachman, Randal H. Henderson, Minesh P. Mehta, Benjamin Movsas, Prospective Evaluation of Quality of Life and Neurocognitive Effects in Patients With Multiple Brain Metastases Receiving Whole-Brain Radiotherapy With or Without Thalidomide on Radiation Therapy Oncology Group (RTOG) Trial 0118, International Journal of Radiation Oncology*Biology*Physics, 2008, 71, 1, 71

    CrossRef

  82. 82
    Mei-Ling Chen, Chih-Teng Yu, Chien-Hui Yang, Sleep disturbances and quality of life in lung cancer patients undergoing chemotherapy, Lung Cancer, 2008, 62, 3, 391

    CrossRef

  83. 83
    Masatoshi Inagaki, Yosuke Uchitomi, Shigeru Imoto, Author reply, Cancer, 2007, 110, 1
  84. 84
    Denise D Correa, Tim A Ahles, Cognitive adverse effects of chemotherapy in breast cancer patients, Current Opinion in Supportive and Palliative Care, 2007, 1, 1, 57

    CrossRef

  85. 85
    Daniel HS Silverman, Steven A Castellon, Patricia A Ganz, Cognitive dysfunction associated with chemotherapy for breast cancer, Future Neurology, 2007, 2, 3, 271

    CrossRef

  86. 86
    Janette Vardy, Ian Tannock, Cognitive function after chemotherapy in adults with solid tumours, Critical Reviews in Oncology/Hematology, 2007, 63, 3, 183

    CrossRef

  87. 87
    Michael H. R. Eichbaum, Andreas Schneeweiss, Christof Sohn, Smaller regional volumes of gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy, Cancer, 2007, 110, 1